Octopus Biosafety (STU:OCR) Stock Based Compensation: €0.00 Mil (TTM As of Dec. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:OCR Octopus Biosafety STU:OCR
1 GF Score
Price €0.10
GF Value €0.05
! 2 Warning Signs
View Full Analysis

What is Octopus Biosafety Stock Based Compensation?

Octopus Biosafety STU:OCR 1 Stock Based Compensation is €0.00 Mil as of Dec. 2024. GuruFocus rates STU:OCR with a GF Score™ of 1/100 and a GF Value™ of €0.05. The stock has 2 warning signs investors should review.

Octopus Biosafety's Stock Based Compensation for the six months ended in Dec. 2024 was €0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00 Mil.

Octopus Biosafety Stock Based Compensation Related Terms

Octopus Biosafety Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Octopus Biosafety's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Octopus Biosafety Stock Based Compensation Chart

Octopus Biosafety Annual Data
Trend Jun14 Jun15 Jun16 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Octopus Biosafety Semi-Annual Data
Jun14 Jun15 Jun16 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
STU:OCR
1GF Score
Octopus Biosafety STU:OCR
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Octopus Biosafety Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00 Mil.

What does a Stock Based Compensation of €0.00 Mil mean?
Octopus Biosafety (STU:OCR) has a Stock Based Compensation of €0.00 Mil as of Dec. 2024. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Octopus Biosafety and its competitors.
Is Octopus Biosafety's Stock Based Compensation too high?
Octopus Biosafety's current Stock Based Compensation is €0.00 Mil. Overall, Octopus Biosafety has a GF Score™ of 1/100, reflecting its overall financial health beyond just this single metric.
How does Octopus Biosafety's Stock Based Compensation compare to SNDK and DELL?
Octopus Biosafety's Stock Based Compensation of €0.00 Mil can be compared against companies in the Hardware industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Hardware company?
A good Stock Based Compensation depends on the Hardware industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Octopus Biosafety and its competitors. Octopus Biosafety's current Stock Based Compensation is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Octopus Biosafety stock overvalued right now?
Octopus Biosafety (STU:OCR) has a current Stock Based Compensation of €0.00 Mil. The stock's GF Value™ is €0.05, compared to a current price of €0.10 — trading 100% above its estimated fair value. The current Stock Based Compensation is €0.00 Mil. Octopus Biosafety's overall GF Score™ is 1/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Octopus Biosafety (STU:OCR), the current Stock Based Compensation is €0.00 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Octopus Biosafety (STU:OCR) Overvalued in 2026?

Based on GuruFocus' analysis, Octopus Biosafety stock appears to be overvalued. The current stock price of €0.10 is trading 100% above its estimated GF Value™ of €0.05.

Key valuation signals for STU:OCR:

  • Stock Based Compensation: €0.00 Mil
  • GF Value™: €0.05 vs. price of €0.10 (100% above fair value)
  • GF Score™: 1/100 with 2 warning signs

No single metric tells the full story. See the STU:OCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Octopus Biosafety Business Description

Other Exchanges MLOCT:France
Address 29 rue Saint Pierre, Cholet, FRA, 49300
Octopus Biosafety is engaged in the design, manufacture and marketing of mobile, autonomous, intelligent and modular robots for use in Agro-food sector, Healthcare sector, Defense sector, Civil Protection sector, and Surveillance and Transport sector.
1GF Score

Get the complete analysis for STU:OCR

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.10
Price
€0.05
GF Value